PubRank

Myron S Cohen

Author PubWeight™ 295.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 2008 16.54
2 Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004 8.30
3 Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005 7.60
4 The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2004 7.04
5 Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 2009 7.01
6 Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med 2011 6.79
7 The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009 6.22
8 The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 2011 5.87
9 Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008 5.85
10 Syphilis in China: results of a national surveillance programme. Lancet 2007 5.76
11 Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004 5.66
12 Population-based study of chlamydial infection in China: a hidden epidemic. JAMA 2003 5.40
13 Pre-exposure prophylaxis for HIV prevention: how to predict success. Lancet 2011 5.34
14 Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis. AIDS 2007 4.89
15 HIV/AIDS risk among brothel-based female sex workers in China: assessing the terms, content, and knowledge of sex work. Sex Transm Dis 2004 4.88
16 AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Science 2005 4.44
17 HIV prevention transformed: the new prevention research agenda. Lancet 2011 4.23
18 Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis 2011 3.78
19 Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS 2007 3.72
20 High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog 2010 3.68
21 Surplus men, sex work, and the spread of HIV in China. AIDS 2005 3.64
22 HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS 2011 3.39
23 Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2006 3.17
24 Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test. J Infect Dis 2011 3.16
25 Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med 2013 3.10
26 HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr 2011 2.49
27 Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis 2006 2.44
28 Frequent detection of acute primary HIV infection in men in Malawi. AIDS 2004 2.43
29 The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 2005 2.31
30 Prostate-specific antigen to ascertain reliability of self-reported coital exposure to semen. Sex Transm Dis 2006 2.31
31 Acute HIV revisited: new opportunities for treatment and prevention. J Clin Invest 2004 2.30
32 Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci U S A 2012 2.27
33 China's syphilis epidemic: a systematic review of seroprevalence studies. Sex Transm Dis 2006 2.23
34 Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health 2006 2.17
35 Accelerating worldwide syphilis screening through rapid testing: a systematic review. Lancet Infect Dis 2010 2.13
36 Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. PLoS Med 2009 2.11
37 Keep them in school: the importance of education as a protective factor against HIV infection among young South African women. Int J Epidemiol 2008 2.00
38 Amplified HIV transmission and new approaches to HIV prevention. J Infect Dis 2005 1.95
39 Improved detection of acute HIV-1 infection in sub-Saharan Africa: development of a risk score algorithm. AIDS 2007 1.89
40 HIV incidence among men who have sex with men in China: a meta-analysis of published studies. PLoS One 2011 1.79
41 Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis 2013 1.77
42 Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS 2012 1.73
43 Single and multiple dose pharmacokinetics of maraviroc in saliva, semen, and rectal tissue of healthy HIV-negative men. J Infect Dis 2011 1.70
44 Pre-exposure prophylaxis and antiretroviral resistance: HIV prevention at a cost? Clin Infect Dis 2011 1.68
45 HIV treatment as prevention: to be or not to be? J Acquir Immune Defic Syndr 2010 1.59
46 Development and validation of a PCR-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J Clin Microbiol 2002 1.58
47 Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. PLoS Pathog 2011 1.57
48 Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 2013 1.55
49 The pharmacokinetics and viral activity of tenofovir in the male genital tract. J Acquir Immune Defic Syndr 2008 1.55
50 HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med 2012 1.55
51 Targeted screening for Trichomonas vaginalis with culture using a two-step method in women presenting for STD evaluation. Sex Transm Dis 2004 1.54
52 Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis 2003 1.52
53 China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses. Curr Opin Infect Dis 2011 1.52
54 Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies. PLoS Comput Biol 2010 1.51
55 HIV-1 Populations in Semen Arise through Multiple Mechanisms. PLoS Pathog 2010 1.47
56 Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women. J Acquir Immune Defic Syndr 2004 1.45
57 Community viral load as a measure for assessment of HIV treatment as prevention. Lancet Infect Dis 2013 1.43
58 Factors related to female sex workers' willingness to utilize VCT service: a qualitative study in Jinan city, northern China. AIDS Behav 2008 1.42
59 Continued high risk sexual behavior following diagnosis with acute HIV infection in South Africa and Malawi: implications for prevention. AIDS Behav 2011 1.41
60 Validation of a urine-based PCR-enzyme-linked immunosorbent assay for use in clinical research settings to detect Trichomonas vaginalis in men. J Clin Microbiol 2003 1.34
61 Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J Clin Microbiol 2006 1.33
62 Preexposure prophylaxis for HIV--where do we go from here? N Engl J Med 2012 1.33
63 Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples. Contemp Clin Trials 2012 1.33
64 Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis 2002 1.33
65 Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS 2011 1.33
66 Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One 2011 1.32
67 Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005 1.31
68 Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection. J Virol 2011 1.28
69 Policies and politics that promote HIV infection in the Southern United States. AIDS 2014 1.28
70 Highly efficient HIV transmission to young women in South Africa. AIDS 2007 1.28
71 An expanding syphilis epidemic in China: epidemiology, behavioural risk and control strategies with a focus on low-tier female sex workers and men who have sex with men. Sex Transm Infect 2011 1.26
72 Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC. Front Microbiol 2011 1.26
73 Risk of syphilis in STI clinic patients: a cross-sectional study of 11,500 cases in Guangxi, China. Sex Transm Infect 2007 1.25
74 A twin response to twin epidemics: integrated HIV/syphilis testing at STI clinics in South China. J Acquir Immune Defic Syndr 2011 1.24
75 Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet 2009 1.23
76 Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J Virol 2011 1.21
77 Does ART prevent HIV transmission among MSM? AIDS 2012 1.20
78 Detection of Acute and Established HIV Infections in Sexually Transmitted Disease Clinics in Guangxi, China: Implications for Screening and Prevention of HIV Infection. J Infect Dis 2007 1.19
79 Sexually transmitted infections among individuals over fifty years of age in China. AIDS Patient Care STDS 2010 1.19
80 How can we better identify early HIV infections? Curr Opin HIV AIDS 2015 1.18
81 Factors associated with utilization of a free HIV VCT clinic by female sex workers in Jinan City, Northern China. AIDS Behav 2011 1.17
82 Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. AIDS 2011 1.16
83 A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in St Petersburg, Russia. J Infect Dis 2010 1.15
84 Azithromycin treatment failure among primary and secondary syphilis patients in Shanghai. Sex Transm Dis 2010 1.15
85 Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design. J Virol 2013 1.15
86 Integrated syphilis/HIV screening in China: a qualitative analysis. BMC Health Serv Res 2010 1.14
87 Investigating a sexual network of black men who have sex with men: implications for transmission and prevention of HIV infection in the United States. J Acquir Immune Defic Syndr 2012 1.14
88 Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells. J Clin Invest 2015 1.13
89 Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication. J Virol 2012 1.13
90 HIV prevention: great achievements, more challenges ahead. J Acquir Immune Defic Syndr 2013 1.11
91 Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis 2010 1.11
92 Differential penetration of raltegravir throughout gastrointestinal tissue: implications for eradication and cure. AIDS 2013 1.08
93 Antiretroviral pharmacology in mucosal tissues. J Acquir Immune Defic Syndr 2013 1.07
94 Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men. J Infect Dis 2002 1.07
95 Scaling up syphilis testing in China: implementation beyond the clinic. Bull World Health Organ 2010 1.07
96 HIV-1 populations in blood and breast milk are similar. Virology 2004 1.06
97 HIV treatment as prevention and "the Swiss statement": in for a dime, in for a dollar? Clin Infect Dis 2010 1.06
98 HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. J Infect Dis 2007 1.05
99 HIV-1 transmission during early antiretroviral therapy: evaluation of two HIV-1 transmission events in the HPTN 052 prevention study. PLoS One 2013 1.04
100 Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest? J Acquir Immune Defic Syndr 2014 1.03
101 Advances in HIV prevention for serodiscordant couples. Curr HIV/AIDS Rep 2014 1.02
102 Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals. J Virol 2011 1.02
103 Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men. J Acquir Immune Defic Syndr 2008 1.02
104 Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples. J Acquir Immune Defic Syndr 2015 1.01
105 Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi. Sex Transm Infect 2010 0.99
106 When people with HIV get syphilis: triple jeopardy. Sex Transm Dis 2006 0.99
107 The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr 2013 0.98
108 A spatial analysis of county-level variation in syphilis and gonorrhea in Guangdong Province, China. PLoS One 2011 0.98
109 Estimating correlation by using a general linear mixed model: evaluation of the relationship between the concentration of HIV-1 RNA in blood and semen. Stat Med 2003 0.97
110 Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retroviruses 2014 0.96
111 Classical sexually transmitted diseases drive the spread of HIV-1: back to the future. J Infect Dis 2012 0.96
112 Sexual partnership patterns in malawi: implications for HIV/STI transmission. Sex Transm Dis 2011 0.96
113 Partner notification uptake for sexually transmitted infections in China: a systematic literature review. Sex Transm Infect 2012 0.94
114 Acute HIV-1 infection in sub-Saharan Africa: a common occurrence overlooked. AIDS 2014 0.92
115 Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins. Virology 2009 0.92
116 The Duffy antigen receptor for chemokines null promoter variant does not influence HIV-1 acquisition or disease progression. Cell Host Microbe 2009 0.92
117 High clade C HIV-1 viremia: how did we get here and where are we going? AIDS 2011 0.92
118 HIV prevention 2010: where are we now and where are we going? Curr Opin HIV AIDS 2010 0.91
119 Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women. Clin Pharmacokinet 2012 0.91
120 Genital tract reservoirs. Curr Opin HIV AIDS 2006 0.91
121 Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi. J Acquir Immune Defic Syndr 2011 0.90
122 The use of specimens from various genitourinary sites in men, to detect Trichomonas vaginalis infection. J Infect Dis 2004 0.90
123 Antiretrovirals for safer conception for HIV-negative women and their HIV-1-infected male partners: how safe and how available? AIDS 2011 0.90
124 Use of nutritional and water hygiene packages for diarrhoeal prevention among HIV-exposed infants in Lilongwe, Malawi: an evaluation of a pilot prevention of mother-to-child transmission post-natal care service. Trop Med Int Health 2010 0.90
125 Decreasing excess mortality of HIV-infected patients initiating antiretroviral therapy: comparison with mortality in general population in China, 2003-2009. J Acquir Immune Defic Syndr 2013 0.89
126 Acute HIV infection among pregnant women in Malawi. Diagn Microbiol Infect Dis 2010 0.88
127 Predicting partner HIV testing and counseling following a partner notification intervention. AIDS Behav 2012 0.87
128 Water, sanitation, and hygiene interventions to improve health among people living with HIV/AIDS: a systematic review. AIDS 2013 0.87
129 Improving the accuracy of syndromic diagnosis of genital ulcer disease in Malawi. Sex Transm Dis 2005 0.87
130 Single- and multiple-dose pharmacokinetics of darunavir plus ritonavir and etravirine in semen and rectal tissue of HIV-negative men. J Acquir Immune Defic Syndr 2012 0.87
131 Models for predicting effective HIV chemoprevention in women. J Acquir Immune Defic Syndr 2015 0.87
132 Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial. J Acquir Immune Defic Syndr 2017 0.87
133 Linkage from HIV testing to care: a positive test often leads nowhere. Sex Transm Dis 2013 0.86
134 Performance of serological tests for syphilis in sexually transmitted diseases clinics in Guangxi Autonomous Region, China: implications for syphilis surveillance and control. Sex Health 2009 0.85
135 Hormonal contraception and HIV: the methods have confused the message. AIDS 2013 0.84
136 Dolutegravir pharmacokinetics in the genital tract and colorectum of HIV-negative men after single and multiple dosing. J Acquir Immune Defic Syndr 2013 0.84
137 Etiology of genital ulcer disease and association with HIV infection in Malawi. Sex Transm Dis 2013 0.84
138 Human immunodeficiency virus type 1 RNA in breast-milk components. J Infect Dis 2003 0.84
139 Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays. Eur J Immunol 2010 0.83
140 Antiretrovirals to prevent HIV infection: pre- and postexposure prophylaxis. Curr Infect Dis Rep 2008 0.83
141 The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi. J Acquir Immune Defic Syndr 2006 0.82
142 STD treatment: how can it improve HIV prevention in the South? Sex Transm Dis 2006 0.82
143 Editorial commentary: China, HIV, and syphilis among men who have sex with men: an urgent call to action. Clin Infect Dis 2013 0.82
144 The HIV treatment cascade in acutely infected people: informing global guidelines. Curr Opin HIV AIDS 2015 0.81
145 Expanding provider-initiated HIV testing at STI clinics in China. AIDS Care 2012 0.81
146 Distribution of the CCR5 gene 32-base pair deletion and CCR5 expression in Chinese minorities. J Acquir Immune Defic Syndr 2003 0.81
147 Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”. Sex Transm Dis 2011 0.80
148 Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. N Engl J Med 2014 0.80
149 Human immunodeficiency virus infection and partner services: a monumental missed opportunity. Sex Transm Dis 2010 0.79
150 Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial. J Acquir Immune Defic Syndr 2016 0.79
151 Honing the test-and-treat HIV strategy. Science 2010 0.79
152 Prior HIV testing among STD patients in Guangdong Province, China: opportunities for expanding detection of sexually transmitted HIV infection. Sex Transm Dis 2012 0.79
153 Unsafe Sex and STI Prevalence Among HIV-Infected Adults in Guangzhou, China: Opportunities to Deamplify Sexual HIV Transmission. AIDS Behav 2013 0.79
154 Determination of amprenavir, a HIV-1 protease inhibitor, in human seminal plasma using high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002 0.76
155 HIV postexposure prophylaxis after sexual assault: why is it so hard to accomplish? Sex Transm Dis 2008 0.76
156 Recent key advances in human immunodeficiency virus medicine and implications for China. AIDS Res Ther 2010 0.76
157 Quantification of Chlamydia trachomatis elementary bodies in urine by ligase chain reaction. J Clin Microbiol 2002 0.75
158 Surveillance of HIV in the United States and England, Scotland, and Northern Ireland: what have we learned and what do we do about it? Sex Transm Dis 2014 0.75
159 Immunologic, virologic, and pharmacologic characterization of the female upper genital tract in HIV-infected women. J Acquir Immune Defic Syndr 2015 0.75
160 HIV antiretroviral postexposure prophylaxis: a cautionary note. Clin Infect Dis 2005 0.75
161 HIV and sexually transmitted diseases. Postgrad Med 1995 0.75
162 A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052. J Acquir Immune Defic Syndr 2017 0.75
163 Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays. J Acquir Immune Defic Syndr 2017 0.75